This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Fondation pour l'Audition | |
|---|---|
| Name | Fondation pour l'Audition |
| Native name | Fondation pour l'Audition |
| Formation | 2015 |
| Type | Philanthropic foundation |
| Headquarters | Paris, France |
| Founder | Elisabeth de Rotschild |
| Focus | Hearing research, hearing health |
Fondation pour l'Audition is a Paris-based philanthropic foundation dedicated to hearing science, audiology, and hearing loss prevention. It supports basic and translational research, clinical innovation, public outreach, and policy advocacy across Europe and internationally. Founded by a member of the Rothschild family, the foundation works with research institutes, hospitals, universities, and industry partners to accelerate discoveries in hearing biology and assistive technologies.
The foundation was established in 2015 through the initiative of Elisabeth de Rothschild and influenced by philanthropic models exemplified by Bill & Melinda Gates Foundation, Wellcome Trust, Howard Hughes Medical Institute, Carnegie Corporation of New York, and Rockefeller Foundation. Early collaborations referenced institutions such as Inserm, CNRS, Collège de France, Université Paris Cité, Sorbonne University, and École Normale Supérieure. Its programmatic design drew on precedent from National Institutes of Health, European Research Council, Medical Research Council (United Kingdom), Agence Nationale de la Recherche, and Institut Pasteur. The foundation's initial grants connected researchers affiliated with Hôpital Necker-Enfants Malades, Hôpital Pitié-Salpêtrière, Institut Curie, Institut Mutualiste Montsouris, and international centers including Massachusetts Institute of Technology, Harvard University, Karolinska Institutet, Max Planck Society, and University of Oxford. Influential advisors included scientists with ties to Institut Pasteur, Cold Spring Harbor Laboratory, Stanford University, and Johns Hopkins University.
The foundation's mission aligns with goals championed by entities like World Health Organization, European Commission, United Nations, World Health Assembly, and G7. Objectives emphasize advancing research into cochlear biology, auditory neuroscience, and sensorineural hearing loss alongside clinical translation—mirroring priorities of European Hearing Health Foundation, American Academy of Audiology, Royal Society, and Academy of Medical Sciences. It seeks to foster interdisciplinary work bridging laboratories such as Institut Curie, Pasteur Institute, and Institute of Neurosciences (Bordeaux) with clinical services at hospitals like Hôpital Necker-Enfants Malades and Hôpital Beaujon. Strategic aims reference frameworks used by NIH BRAIN Initiative, Horizon 2020, Horizon Europe, Human Frontier Science Program, and European Innovation Council.
Research programs support basic science, translational projects, and clinical trials. Funded areas overlap with groups at CNRS Unit 8195, INSERM Unit 1120, Institut de l'Audition, ICM (Brain and Spine Institute), Institut du Cerveau, and laboratories at École Polytechnique. Grant mechanisms resemble those of European Research Council, Fondation Bettencourt Schueller, Fondation Simone et Cino Del Duca, Fondation pour la Recherche Médicale, and Wellcome Trust. Projects include gene therapy studies akin to work at Stanford University School of Medicine, optogenetics inspired by research at Max Planck Institute for Biological Intelligence, and prosthetic developments paralleling efforts at University College London, Johns Hopkins University Applied Physics Laboratory, and Johns Hopkins Hospital. The foundation has supported clinical collaborations for cochlear implants comparable to programs at Cochlear Limited, MED-EL, Advanced Bionics, and academic centers at Karolinska University Hospital and Massachusetts Eye and Ear Infirmary. Training fellowships mirror schemes from Marie Skłodowska-Curie Actions, Fulbright Program, Alexander von Humboldt Foundation, and EMBO.
Public initiatives target prevention, screening, and awareness, building on campaigns like those by World Hearing Forum, European Association of Audiology, International Federation of ORL Societies, European Society of Paediatric Otorhinolaryngology, and Action on Hearing Loss. Programs have engaged cultural partners such as Opéra National de Paris, Musée du quai Branly, Palais Garnier, Festival d'Avignon, and media organizations including Radio France, France Télévisions, Le Monde, Le Figaro, and The New York Times for outreach. Educational collaborations involved institutions like Conservatoire de Paris, Sibelius Academy, Royal College of Music, Royal Opera House, and schools such as Lycée Louis-le-Grand and École Alsacienne. Screening campaigns complemented efforts by Réseau Sentinelle, French Red Cross, Médecins Sans Frontières, and community programs modeled on National Deaf Children's Society.
The foundation partners with academic, clinical, industry, and nonprofit organizations. Academic partners include Université PSL, École Normale Supérieure de Lyon, Aix-Marseille Université, Université Grenoble Alpes, University of Cambridge, Imperial College London, ETH Zurich, Duke University, and University of Toronto. Clinical partners include Hôpital Robert Debré, Hôpital Necker, Great Ormond Street Hospital, and Massachusetts General Hospital. Industry collaborations involve Sanofi, Novartis, Roche, Philips, Siemens Healthineers, and startups in otology. Nonprofit collaborators include Fondation de France, Fondation Bettencourt Schueller, European Federation of Audiological Societies, Action on Hearing Loss, and Helen Keller International. International research networks referenced include Cochlear Implant International Community of Practice, Global Research on Hearing Loss Consortium, and International Consortium for Hearing Research.
Governance structures draw on models used by Rothschild family philanthropic boards, Fondation de France, Carnegie Endowment for International Peace, and The Rockefeller Foundation. The board and scientific advisory committees have featured figures from Collège de France, Institut Pasteur, Harvard Medical School, University College London, Karolinska Institutet, and Stanford School of Medicine. Funding sources include endowment contributions comparable to Fondation Bettencourt Schueller and targeted grants co-funded with European Commission programs like Horizon Europe and philanthropic partners such as Bill & Melinda Gates Foundation and Wellcome Trust. Financial oversight practices reflect standards from Autorité des marchés financiers, Cour des comptes (France), and International Financial Reporting Standards.
The foundation has initiated prizes and awards to recognize research excellence, modeled after Lasker Award, Nobel Prize in Physiology or Medicine, Brain Prize, European Research Council Advanced Grant, and Breakthrough Prize. Recipients have included investigators with affiliations to Institut Pasteur, Karolinska Institutet, Harvard Medical School, Massachusetts Institute of Technology, University of California, San Francisco, and Max Planck Society. The foundation's programs and leaders have been profiled in outlets such as Nature, Science (journal), The Lancet, BMJ, and PLOS Biology.
Category:Foundations based in France